WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Theraclion wins a De Novo for treating varicose veins with focused ultrasound Onkos Surgical extends its antibacterial coating to more ELEOS titanium parts Siemens Healthineers names its diagnostics carve-out Olyrian and sets mid-2028 FX Shoulder clears the first stemless reverse shoulder system sold in the US Edwards raises its 2026 outlook a third time on $1.24B of TAVR sales CMS pays non-contrast imaging the same rate in hospitals and offices from 2027 Mobia Medical lifts 2026 guidance after a 73 percent revenue quarter PulseAI clears an arrhythmia model that reads single-lead ECG from wearables Baird Medical's partner files a 510(k) for an irreversible electroporation system Theraclion wins a De Novo for treating varicose veins with focused ultrasound Onkos Surgical extends its antibacterial coating to more ELEOS titanium parts Siemens Healthineers names its diagnostics carve-out Olyrian and sets mid-2028 FX Shoulder clears the first stemless reverse shoulder system sold in the US Edwards raises its 2026 outlook a third time on $1.24B of TAVR sales CMS pays non-contrast imaging the same rate in hospitals and offices from 2027 Mobia Medical lifts 2026 guidance after a 73 percent revenue quarter PulseAI clears an arrhythmia model that reads single-lead ECG from wearables Baird Medical's partner files a 510(k) for an irreversible electroporation system

The Tracker / September 2026 / K262202

510(k) cleared

Cerasmart Forte

GC America, Inc. · Sep 10, 2026 · K262202

FDA cleared the Cerasmart Forte from GC America, Inc. on Sep 10, 2026 under K262202, a traditional 510(k). The device falls under product code EBF, Material, Tooth Shade, Resin, regulated at 21 CFR 872.3690 as a Class 2 device. The review panel was Dental.

FDA logged the submission as received on Jun 29, 2026. The decision came 73 days later, inside the 90 FDA-day goal for a 510(k).

GC America, Inc. has 8 other decisions in the tracker over the last 12 months: K262126 (Cerclage Wires;K-wires;Steinmann Pins), K261217 (AnyPlus II Spinal Fixation System), K254302 (ECG Analysis Software (AiTiALVSD)), K260250 (QCA 10 Electrocardiograph (QCARD-10); QCA 10W Electrocardiograph (QCARD-10W)).

Questions & Answers

What did FDA clear under K262202?

K262202 is the FDA 510(k) for Cerasmart Forte, submitted by GC America, Inc.. FDA's decision date was Sep 10, 2026, under product code EBF (Material, Tooth Shade, Resin).

Who makes the Cerasmart Forte?

GC America, Inc., based in Alsip, IL, is the applicant of record for K262202.

How long did the K262202 review take?

FDA received the submission on Jun 29, 2026 and issued its decision on Sep 10, 2026, 73 days later.

← All decisions in September 2026